Reduced cholinergic status in hippocampus produces spatial memory deficits when combined with kainic acid induced seizures

Hippocampus

Volumn 18, Issue 11, 2008, Pages 1112-1121

  Craig, Laura A ^a   Hong, Nancy S ^a   Kopp, Joelle ^a   McDonald, Robert J ^a  

^a UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

192 IgG saporin; Acetylcholine (ACh); Alzheimer's disease; Co factors; Memory

Indexed keywords

KAINIC ACID; SAPORIN;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; RISK FACTOR; SEIZURE; SPATIAL MEMORY; TASK PERFORMANCE;

ACETYLCHOLINE; ALZHEIMER DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL; CHOLINERGIC AGENTS; CONVULSANTS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KAINIC ACID; MALE; MEMORY DISORDERS; RATS; RATS, LONG-EVANS; RIBOSOME INACTIVATING PROTEINS, TYPE 1; RISK FACTORS; SEIZURES; SPATIAL BEHAVIOR;

EID: 55549083891     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20471     Document Type: Article

References (41)

1. Baxter MG, Gallagher M. 1996. Intact spatial learning in both young and aged rats following selective removal of hippocampal cholinergic input. Behav Neurosci 110:460-467.
2. Bellucci A, Luccarini I, Scali C, Prosperi C, Giovannini MG, Pepeu G, Casamenti F. 2006. Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice. Neurobiol Dis 23:260-272.
3. Bowen DM, Benton JS, Spillane JA, Smith CC, Allen SJ. 1982. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J Neurol Sci 57:191-202.
4. Craig LA, McDonald RJ. 2005. Multiple combinations of co-factors produce variants of age-related cognitive decline. Washington, D.C: Society for Neuroscience (Abstract).
5. Craig LA, Hong NS, Kopp J, McDonald RJ. 2008. Emergence of spatial impairment in rats following specific cholinergic depletion of the medial septum combined with chronic stress. Eur J Neurosci 27:2262-2271.
6. Davies P, Maloney AJ. 1976. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2:1403.
7. Del Vecchio RA, Gold LH, Novick SJ, Wong G, Hyde LA. 2004. Increased seizure threshold and severity in young transgenic CRND8 mice. Neurosci Lett 367:164-167.
8. Driscoll I, Hong NS, Craig LA, Sutherland RJ, McDonald RJ. 2007. Enhanced cell death and learning deficits after a mini-stroke in aged hippocampus. Neurobiol Aging doi:10.1016/j.neurobiolaging.2007.04.025
9. Ferencz I, Kokaia M, Keep M, Elmer E, Metsis M, Kokaia Z, Lindvall O. 1997. Effects of cholinergic denervation on seizure development and neurotrophin messenger RNA regulation in rapid hippocampal kindling. Neuroscience 80:389-399.
10. Ferencz I, Leanza G, Nanobashvili A, Kokaia Z, Kokaia M, Lindvall O. 2001. Septal cholinergic neurons suppress seizure development in hippocampal kindling in rats: Comparison with noradrenergic neurons. Neuroscience 102:819-832.
11. Frick KM, Kim JJ, Baxter MG. 2004. Effects of complete immunotoxin lesions of the cholinergic basal forebrain on fear conditioning and spatial learning. Hippocampus 14:244-254.
12. Frielingsdiorf H, Thal LJ, Pizzo DP. 2006. The septohippocampal system and spatial working memory in the Morris water maze. Behav Brain Res 168:609-613.
13. Gallagher M, Comlombo PJ. 1995. Ageing: The cholinergic hypothesis of cognitive decline. Curr Opin Neurobiol 5:161-168.
14. Gayoso MJ, Primo C, Al-Majdalawi A, Fernandez JM, Garrosa M, Iniguez C. 1994. Brain lesions and water-maze learning deficits after systemic administration of kainic acid to adult rats. Brain Res 653:92-100.
15. Geddes JW, Cotman CW. 1986. Plasticity in hippocampal excitatory amino acid receptors in Alzheimer's disease. Neurosci Res 3:672-678.
16. Gobbo OL, O'Mara SM. 2004. Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration. Neuroscience 125:317-327.
17. Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, Martin GM, Mattson MP. 1999. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med 5:101-106.
18. Hauser WA, Morris ML, Heston LL, Anderson VE. 1986. Seizures and myoclonus in patients with Alzheimer's disease. Neurology 36:1226-1230.
19. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA. 1996. Dementia and adult-onset unprovoked seizures. Neurology 46:727-730.
20. Jaspers RMA, Block F, Heim C, Sontag KH. 1990. Spatial learning is affected by transient occlusion of common carotid arteries (2VO): Comparison of behavioural and histopathological changes after '2VO' and 'four-vessel- occlusion' in rats. Neurosci Lett 117:149-153.
21. Jouvenceau A, Billard JM, Lamour Y, Dutar P. 1996. Persistence of CA1 hippocampal LTP after selective cholinergic deafferentation in rats. Neuroreport 7:948-952.
22. Jouvenceau A, Billard JM, Lamour Y, Dutar P. 1997. Potentiation of glutamatergic EPSP's in rat CA1 hippocampal neurons after selective cholinergic denervation by 192 IgG-saporin. Synapse 26:292-300.
23. Kiyota Y, Miyamoto M, Nagaoka A. 1991. Relationship between brain damage and memory impairment in rats exposed to transient forebrain ischemia. Brain Res 538:295-302.
24. Kokaia M, Ferencz I, Leanza G, Elmer E, Metsis M, Kokaia Z, Wiley RG, Lindvall O. 1996. Immunolesioning of basal forebrain cholinergic neurons facilitates hippocampal kindling and perturbs neurotrophin messenger RNA regulation. Neuroscience 70:313-327.
25. Lothman EW, Collins RC. 1981. Kainic acid induced limbic seizures: Metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res 218:299-318.
26. McDonald RJ. 2002. Multiple combinations of co-factors produce variants of age-related cognitive decline: A theory. Can J Exp Psychol 56:221-239.
27. McDonald RJ, Hong NS, Craig LA, Holahan MR, Louis M, Muller RU. 2005. NMDA-receptor blockade by CPP impairs post-training consolidation of a rapidly acquired spatial representation in rat hippocampus. Eur J Neurosci 22:1201-1213.
28. McDonald RJ, Craig LA, Hong NS. 2007. Enhanced cell death in hippocampus and emergence of cognitive impairments following a localized mini-stroke in hippocampus if preceded by a previous episode of acute stress. Eur J Neurosci 27:2197-2209.
29. Mesulam M. 2004. The cholinergic lesion of Alzheimer's disease: Pivotal factor or side show? Learn Mem 11:43-49.
30. Mikulecka A, Hlinak Z, Mares P. 1999. Behavioral effects of a subconvulsive dose of kainic acid in rats. Behav Brain Res 101:21-28.
31. Milgram NW, Isen DA, Mandel D, Palantzas H, Pepkowski MJ. 1988. Deficits in spontaneous behavior and cognitive function following systemic administration of kainic acid. Neurotoxicol 9:611-624.
32. Morley JE. 2002. The SAMP8 mouse: A model of Alzheimer's disease? Biogerontology 3:57-60.
33. Nedelmann M, Wilhelm-Schwenkmezger T, Alessandri B, Heimann A, Schneider F, Eicke BM, Dieterich M, Kempski O. 2007. Cerebral embolic ischemia in rats: Correlation of stroke severity and functional deficit as important outcome parameter. Brain Res 1130:188-196.
34. Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Shaw PJ, Ince PG, Brown A, Perry RH. 1992. Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol Aging 13:393-400.
35. Reisberg B, Doody R, Stoffler A. 2003. A randomized, placebo controlled study of memantine, an uncompetitive NMDA antagonists, in patients with moderate to severe Alzheimer's disease. N Engl J Med 348:1333-1341.
36. Romanelli MF, Morris JC, Ashkin K, Coben LA. 1990. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol 47:847-850.
37. Schliebs R, Arendt T. 2006. The significance of the cholinergic system in the brain during aging and Alzheimer's disease. J Neural Transm 113:1625-1644.
38. Silveira DC, Holmes GL, Schachter SC, Geula C, Schomer DL. 2000. Increased susceptibility to generalized seizures after immunolesions of the basal forebrain cholinergic neurons in rats. Brain Res 878:223-227.
39. Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I. 2004. Memantine treatment in patients with moderate to severe Alzheimer's disease already receiving donepezil: A randomized controlled trial. JAMA 291:317-324.
40. Walh F, Allix M, Plotkine M, Boulu RG. 1992. Neurological and behavioural outcomes of focal ischemia in rats. Stroke 23:267-272.
41. Yamaguchi T, Suzuki M, Yamamoto M. 1995. YM796, a novel muscarinic agonist, improves the impairment of learning behaviour in a rat model of chronic focal cerebral ischemia. Brain Res 669:107-114.